286 related articles for article (PubMed ID: 22281166)
21. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
22. Use of leukotriene receptor antagonists are associated with a similar risk of asthma exacerbations as inhaled corticosteroids.
Wu AC; Li L; Fung V; Kharbanda EO; Larkin EK; Vollmer WM; Butler MG; Miroshnik I; Rusinak D; Davis RL; Hartert T; Weiss ST; Lieu TA
J Allergy Clin Immunol Pract; 2014; 2(5):607-13. PubMed ID: 25213056
[TBL] [Abstract][Full Text] [Related]
23. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
Chan J; Hui RL; Spence MM
J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular safety of long acting beta agonist-inhaled corticosteroid combination products in adult patients with asthma: a systematic review.
Iftikhar IH; Imtiaz M; Brett AS; Amrol DJ
Lung; 2014 Feb; 192(1):47-54. PubMed ID: 24153452
[TBL] [Abstract][Full Text] [Related]
25. Rates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: an exploratory post-hoc analysis.
Dal Negro RW; Borderias L; Zhang Q; Fan T; Sazonov V; Guilera M; Taylor SD
BMC Pulm Med; 2009 Mar; 9():10. PubMed ID: 19331689
[TBL] [Abstract][Full Text] [Related]
26. Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study.
Sadatsafavi M; Lynd LD; Marra CA; FitzGerald JM
Thorax; 2014 Apr; 69(4):328-34. PubMed ID: 24281327
[TBL] [Abstract][Full Text] [Related]
27. Comparative safety and effectiveness of inhaled bronchodilators and corticosteroids for treating asthma-COPD overlap: a systematic review and meta-analysis.
Amegadzie JE; Gorgui J; Acheampong L; Gamble JM; Farrell J; Gao Z
J Asthma; 2021 Mar; 58(3):344-359. PubMed ID: 31668101
[TBL] [Abstract][Full Text] [Related]
28. Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Postma DS; Kerstjens HA; ten Hacken NH
Naunyn Schmiedebergs Arch Pharmacol; 2008 Aug; 378(2):203-15. PubMed ID: 18500509
[TBL] [Abstract][Full Text] [Related]
29. Add-on tiotropium versus step-up inhaled corticosteroid plus long-acting beta-2-agonist in real-world patients with asthma.
Chipps B; Mosnaim G; Mathur SK; Shaikh A; Khoury S; Gopalan G; Palli SR; Lamerato L; Casciano J; Dotiwala Z; Settipane R
Allergy Asthma Proc; 2020 Jul; 41(4):248-255. PubMed ID: 32414426
[No Abstract] [Full Text] [Related]
30. Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review.
Rodrigo GJ; Moral VP; Marcos LG; Castro-Rodriguez JA
Pulm Pharmacol Ther; 2009 Feb; 22(1):9-19. PubMed ID: 19026757
[TBL] [Abstract][Full Text] [Related]
31. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.
Sobieraj DM; Weeda ER; Nguyen E; Coleman CI; White CM; Lazarus SC; Blake KV; Lang JE; Baker WL
JAMA; 2018 Apr; 319(14):1485-1496. PubMed ID: 29554195
[TBL] [Abstract][Full Text] [Related]
32. Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma.
van Aalderen WM; Grigg J; Guilbert TW; Roche N; Israel E; Martin RJ; Colice G; Postma DS; Hillyer EV; Burden A; Thomas V; von Ziegenweidt J; Price D
J Allergy Clin Immunol Pract; 2015; 3(5):721-31.e16. PubMed ID: 26032474
[TBL] [Abstract][Full Text] [Related]
33. Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: A retrospective US claims study.
Duh MS; Roberts MH; Rothnie KJ; Cheng WY; Thompson-Leduc P; Zhang S; Czira A; Slade D; Greatsinger A; Zhang A; Mapel D
Respir Med; 2024 May; 226():107629. PubMed ID: 38593885
[TBL] [Abstract][Full Text] [Related]
34. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
[TBL] [Abstract][Full Text] [Related]
35. [Persistence to treatment and resources use with inhaled fixed-dose combinations of corticosteroids and long-acting β-adrenergic agonists for the treatment of asthma: A population-based retrospective study].
Sicras-Mainar A; Traseira-Lugilde S; Fernández-Sánchez T; Navarro-Artieda R
Semergen; 2018 Oct; 44(7):472-484. PubMed ID: 29545018
[TBL] [Abstract][Full Text] [Related]
36. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
Hanania NA
Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
[TBL] [Abstract][Full Text] [Related]
37. Stepping down asthma treatment: how and when.
Rogers L; Reibman J
Curr Opin Pulm Med; 2012 Jan; 18(1):70-5. PubMed ID: 22081088
[TBL] [Abstract][Full Text] [Related]
38. Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study.
Kuna P
Clin Drug Investig; 2010; 30(9):565-79. PubMed ID: 20593912
[TBL] [Abstract][Full Text] [Related]
39. The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma.
Mansfield LE
Allergy Asthma Proc; 2008; 29(2):103-8. PubMed ID: 18430306
[TBL] [Abstract][Full Text] [Related]
40. Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β
Buhl R; FitzGerald JM; Busse WW
Respir Med; 2018 Oct; 143():82-90. PubMed ID: 30261998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
